11
Jun
2026
11
Jun
2026
Medecan is a UK-based CQC-registered medical cannabis clinic offering safe, regulated and evidence-led access to cannabis-based medicines for patients who have not responded to conventional treatments. The clinic operates under strict medical governance, using GMC-registered specialists, MHRA-approved supply chains and multidisciplinary clinical reviews.
Medecan, a new UK-based CQC-registered medical cannabis clinic, has officially launched with a clear mission: to demystify medical cannabis and provide safe, regulated, evidence-led access for patients who have exhausted conventional treatment options.
Founded by an experienced NHS GP with more than three decades in clinical practice, alongside a multidisciplinary leadership team spanning biomedical science, healthcare operations and cannabis cultivation and production, Medecan has been created in response to a clear gap in UK patient care.
While medical cannabis has been legal on prescription from a GMC-registered specialist doctor since 2018, awareness, understanding, and access remain limited.
It is estimated that around 1.8 million people in the UK already use cannabis illicitly for medical reasons¹², while only a fraction currently access it legally through prescription. In addition, a quarter of adults are unaware that medical cannabis can be legally prescribed³.
Medecan aims to change that by offering a fully regulated, transparent and clinically robust pathway for patients living with:
“Like many clinicians, my early experience of cannabis was shaped by only seeing the harms of high-THC (Tetrahydrocannabinol) recreational use,” says Dr David Eccleston, Co-Founder and Chief Medical Officer of Medecan. “It was only after seeing the science, regulation and patient outcomes associated with medical cannabis that my perspective completely changed. This is not about ‘getting high’ – it’s about carefully balanced, reproducible medicine that can transform quality of life.”
Medecan operates under strict UK regulatory frameworks, working with licensed pharmacies and MHRA-approved supply chains.
All products are prescribed only after:
The clinic offers a fully virtual pathway, enabling patients to complete eligibility screening, consultations and follow-ups from home.
Where appropriate, prescriptions are dispensed via Special Delivery to the patient’s home in discreet medical formats including:
This avoids the stigma and risks associated with illicit or smoked cannabis products.
“Our goal is to medicalise this space,” says Laura Eccleston, Co-Founder and Chief Resources Officer. “We’re not here to legitimise recreational use. We’re here for those patients who feel like they have tried everything and need a new, clinically supported option.”
Medecan takes a whole-patient approach, recognising that chronic conditions often overlap across:
Medical cannabis interacts with the body’s endocannabinoid system, a network of receptors involved in pain, mood, inflammation and sleep regulation. This helps explain why carefully prescribed cannabis-based medicines may support multiple interconnected symptoms.
“We see patients who’ve tried opioids, antidepressants and sleeping tablets, often with limited benefit or intolerable side effects,” adds Dr Eccleston. “Medical cannabis offers something different – personalised, non-addictive and often better tolerated when prescribed correctly.”
Medecan positions itself apart from parts of the sector that have faced criticism for inconsistent governance or prescribing practices.
Key safeguards include:
The clinic works with UK-based producers and licensed suppliers to ensure consistency and pharmaceutical-grade quality.
Cannabis plants are grown as genetically identical clones, allowing precise control over cannabinoid and terpene profiles and ensuring consistent quality between batches.
This supports reproducible, standardised prescribing rather than variability associated with illicit cannabis products.
“Transparency, ethics and patient trust are non-negotiable for us,” says Laura. “We want Medecan to feel more like a trusted healthcare partner than a ‘clinic’. Demystifying medical cannabis is just as important as prescribing it.”
Medecan plans to:
“Our ambition is simple,” Dr Eccleston concludes. “To help patients feel better, function better and live better – using medicine that has been underutilised and misunderstood for far too long.”
Watch Dr Eccleston speaking about medical cannabis here:
https://youtu.be/xXNwhzG4fKs?si=u9UzvomHso8-37gR
Read it? Loved it? Want to share it?
